Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000464312 | SCV000548967 | benign | Adams-Oliver syndrome 5 | 2022-06-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001799662 | SCV002044046 | uncertain significance | not provided | 2022-11-30 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25793878) |
Genome- |
RCV000464312 | SCV002553371 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270510 | SCV002553372 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004022718 | SCV003562757 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-03-29 | criteria provided, single submitter | clinical testing | The p.S1690L variant (also known as c.5069C>T), located in coding exon 27 of the NOTCH1 gene, results from a C to T substitution at nucleotide position 5069. The serine at codon 1690 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this alteration remains unclear. |